Non-Hodgkin's Lymphoma in Childhood and Adolescence 2019
DOI: 10.1007/978-3-030-11769-6_20
|View full text |Cite
|
Sign up to set email alerts
|

Anaplastic Large Cell Lymphoma in Children and Adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 96 publications
0
9
0
Order By: Relevance
“…Current trials incorporate these drugs into first-line therapy, which will likely change treatment paradigms for this disease and further improve long-term outcomes. 20 Our patient had no involvement of her bone marrow or central nervous system, and she had no skin lesions. Her signs and symptoms resolved quickly with chemotherapy, with a complete response after 2 chemotherapy cycles.…”
Section: Dr Belyeamentioning
confidence: 61%
See 2 more Smart Citations
“…Current trials incorporate these drugs into first-line therapy, which will likely change treatment paradigms for this disease and further improve long-term outcomes. 20 Our patient had no involvement of her bone marrow or central nervous system, and she had no skin lesions. Her signs and symptoms resolved quickly with chemotherapy, with a complete response after 2 chemotherapy cycles.…”
Section: Dr Belyeamentioning
confidence: 61%
“…Most patients present at advanced stages, with primary abdominal or mediastinal disease. 20 They often have systemic signs and symptoms (fever, weight loss, and night sweats) and frequently have extranodal disease in skin, liver, lung, soft tissues, and bone. 21 These inflammatory symptoms can be troubling yet nonspecific.…”
Section: Dr Belyeamentioning
confidence: 99%
See 1 more Smart Citation
“…[3][4][5]8,11 However, when compared to the approximately 70% survival rate for pediatric ALCL, the most common and well-studied mature T-cell lymphoma in children, PNKTCL shows a worse prognosis, although the case series by Kobayashi et al 4 exhibited a high ALCL-like survival rate of 85%. 21 When examining their data, these better outcomes may have resulted from having a lower rate of EBV infection. Also, their data set contained no cases of systemic EBV-positive TCLC, an entity with dismal survival that would surely bring down the overall mortality rate.…”
Section: A Diagnosis Of Exclusion Ptcl-nos Includes a Heterogenous Smentioning
confidence: 99%
“…Anaplastic large cell lymphoma (ALCL) accounts for 20-30% of childhood non-Hodgkin lymphoma (NHL) 1,2 and often presents with advanced-stage disease. Disease recurrence develops in 20%-40% of patients.…”
Section: Introductionmentioning
confidence: 99%